In Ayurveda all the Skin disorders are explained under Kustharogaadhikarand classified as 7 Mahakusthasand 11Kshudrakusthas .Kitibhakustha and Ekakustha are among the KshudraKusthas. Kitibhakusthais characterized by symptoms like Shyavam( blackish brown/ash colour lesions), kina Rauksham (hard and dry in nature), Kharasparsha(rough on touch), ugrakandu(excessive itching) and Ekakustha have symptoms like aswedanam(loss of sweating), mahavastu(covering of large surface areas ), matsyashakalopam(scaly lesions ) with predominance of vata and kaphadoshas in both.Due to similarities in symptoms it can be correlated to Plaque Psoriasis. It is chronic in nature and mainly caused due to autoimmune factor characterized by sharply defined erythematous squamous lesion, reddish scaly patches on the skin. AcharyaCharak has indicated repeated shodhanaand shaman chikitsa for kustha.Inbahyachikitsaapplication of various tailsand lepas are described. Thus the aim of the study is to review and discuss various external applications described in Psoriasis as per Ayurveda.Methodology- The classical texts of Ayurveda and modern medicine, Journals and Research articles were reviewed. Observations and Discussion- In the study following formulations like Dhatrayadhyolepa, Kutajasuryapakitaila, Karanjabeejataila showed significant result in reducing the symptoms of Psoriasis .Conclusion- Psoriasis(kustha)can be managed effectively by Lepachikitsathat is local application of various medicated herbs in form of lepa, and tails.
Background-Raised total cholesterol, high LDL-C, low HDL-C, and elevated triglycerides are all symptoms of dyslipidemia. It is included in metabolic disorders. It is a major component in causation of atherosclerosis, coronary artery disease and cerebrovascular disease. There is a 1-2 percent rise in the incidence of Coronary Heart Disease for every 1% increase in cholesterol level. As per Ayurveda, it can be considered as a Medadhatu Dushti that is “Medoroga”. Acharya Charaka described drugs having deepana, pachana, medohar, lekhana and strotoshodhaka properties for management of Medoroga. Kutaki (Picrorhiza kurroa Royle ex. Benth) can be used in such conditions due to its lekhana and medohar properties.Various animal research studies conducted on Kutaki proved its antihyperlipidemic and hepatoprotective property. Hence in this case series three patients of dyslipidemia were treated with single dravya Kutaki in tablet form. Case Report-All the three female patients, aged between 40 to 50 years, were treated with Kutaki tablet (500mg) two times a day in the morning and evening (8am-8pm) empty stomach with water for 60 days. After completion of treatment, assessment was done by comparing Serum lipid profile value as with baseline after completion of treatment. Observations and Result -All the three patients showed improvement in lipid values. There was no change in weight or BMI was noted. Conclusion-Hence, it can be concluded that Kutaki is safe and effective in dyslipidemia for normalization of lipid in the blood due to its lekhana, Kapha Medohara (alleviation of vitiated Kapha and Meda) properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.